• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猴痘疫苗接种和治疗:系统评价。

Mpox vaccination and treatment: a systematic review.

机构信息

Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

J Chemother. 2024 Apr;36(2):85-109. doi: 10.1080/1120009X.2023.2289270. Epub 2023 Dec 9.

DOI:10.1080/1120009X.2023.2289270
PMID:38069596
Abstract

The Human monkeypox virus (mpox) belongs to the Poxviridae family, characterized by double-stranded DNA. A 2022 outbreak, notably prevalent among men who have sex with men, was confirmed by the World Health Organization. To understand shifting prevalence patterns and clinical manifestations, we conducted a systematic review of recent animal and human studies. We comprehensively searched PubMed, Scopus, Web of Science, Cochrane Library, and Clinicaltrials.gov, reviewing 69 relevant articles from 4,342 screened records. Our analysis highlights Modified Vaccinia Ankara - Bavarian Nordic (MVA-BN)'s potential, though efficacy concerns exist. Tecovirimat emerged as a prominent antiviral in the recent outbreak. However, limited evidence underscores the imperative for further clinical trials in understanding and managing monkeypox.

摘要

人类猴痘病毒(mpox)属于痘病毒科,其特征是双链 DNA。世界卫生组织证实,2022 年爆发的疫情主要在男男性行为者中流行。为了了解流行趋势和临床表现的变化,我们对最近的动物和人类研究进行了系统综述。我们全面检索了 PubMed、Scopus、Web of Science、Cochrane Library 和 Clinicaltrials.gov,从 4342 篇筛选记录中回顾了 69 篇相关文章。我们的分析强调了改良安卡拉痘苗-巴伐利亚北欧株(MVA-BN)的潜力,尽管存在疗效方面的担忧。特考韦瑞玛特在最近的疫情中成为一种重要的抗病毒药物。然而,有限的证据强调了进一步临床试验的必要性,以了解和管理猴痘。

相似文献

1
Mpox vaccination and treatment: a systematic review.猴痘疫苗接种和治疗:系统评价。
J Chemother. 2024 Apr;36(2):85-109. doi: 10.1080/1120009X.2023.2289270. Epub 2023 Dec 9.
2
Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response.儿童单次接种改良安卡拉-巴伐利亚北欧天花疫苗后的安全性、反应原性和免疫应答的早期评估:国家疫情应对。
Lancet Infect Dis. 2023 Sep;23(9):1042-1050. doi: 10.1016/S1473-3099(23)00270-0. Epub 2023 Jun 16.
3
Current Status of Vaccine Development for Monkeypox Virus.猴痘病毒疫苗研发的现状。
Adv Exp Med Biol. 2024;1451:289-300. doi: 10.1007/978-3-031-57165-7_18.
4
Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.2022 年至 2023 年,荷兰对高危人群进行 MVA-BN 疫苗接种后 1 年,痘病毒特异性抗体降至无法检测的水平。
Euro Surveill. 2024 Sep;29(38). doi: 10.2807/1560-7917.ES.2024.29.38.2400575.
5
Characterizing the acute antibody response of monkeypox and MVA-BN vaccine following an Australian outbreak.描述澳大利亚猴痘疫情后,天花疫苗和 MVA-BN 疫苗的急性抗体反应。
J Med Virol. 2024 Jan;96(1):e29407. doi: 10.1002/jmv.29407.
6
Treatment and Vaccination for Smallpox and Monkeypox.天花和猴痘的治疗和疫苗接种。
Adv Exp Med Biol. 2024;1451:301-316. doi: 10.1007/978-3-031-57165-7_19.
7
Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study.使用病例覆盖法评估英格兰一剂 MVA-BN 天花疫苗对猴痘的有效性:一项观察性研究。
Lancet Infect Dis. 2023 Jul;23(7):828-835. doi: 10.1016/S1473-3099(23)00057-9. Epub 2023 Mar 13.
8
Vaccines against mpox: MVA-BN and LC16m8.针对猴痘的疫苗:MVA-BN 和 LC16m8。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):796-811. doi: 10.1080/14760584.2024.2397006. Epub 2024 Sep 1.
9
Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial.改良安卡拉痘苗-巴伐利亚北欧疫苗预防猴痘感染的效果:目标试验模拟。
BMJ. 2024 Sep 11;386:e078243. doi: 10.1136/bmj-2023-078243.
10
Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis.猴痘(mpox)病毒:分类、起源、传播、基因组组织、抗病毒药物和分子诊断。
J Infect Public Health. 2023 Apr;16(4):531-541. doi: 10.1016/j.jiph.2023.02.003. Epub 2023 Feb 9.

引用本文的文献

1
Mpox: current knowledge and understanding-a scoping review.猴痘:当前的知识与理解——一项范围综述
FEMS Microbiol Rev. 2025 Jan 14;49. doi: 10.1093/femsre/fuaf025.
2
Current status of next-generation vaccines against mpox virus: a scoping review.抗猴痘病毒的下一代疫苗的现状:一项范围综述
Front Pharmacol. 2025 Apr 28;16:1533533. doi: 10.3389/fphar.2025.1533533. eCollection 2025.
3
Risk factors associated with human Mpox infection: a systematic review and meta-analysis.与人类猴痘感染相关的风险因素:一项系统综述和荟萃分析。
BMJ Glob Health. 2025 Feb 3;10(2):e016937. doi: 10.1136/bmjgh-2024-016937.
4
Viral genetics and transmission dynamics in the second wave of mpox outbreak in Portugal and forecasting public health scenarios.葡萄牙第二波猴痘疫情中的病毒遗传学和传播动态及公共卫生情景预测。
Emerg Microbes Infect. 2024 Dec;13(1):2412635. doi: 10.1080/22221751.2024.2412635. Epub 2024 Oct 11.
5
The Feasibility of Elimination of Monkeypox Virus in Nigeria: A Systematic Review.尼日利亚消除猴痘病毒的可行性:一项系统评价
Cureus. 2024 Jun 7;16(6):e61867. doi: 10.7759/cureus.61867. eCollection 2024 Jun.